Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0DUQPX
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
B2E5-ADC
|
|||||
| Synonyms |
B2E5-ADC
Click to Show/Hide
|
|||||
| Organization |
CURED INC. | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY | NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEM
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
3.8
|
|||||
| Antibody Name |
B2E5-48 antibody H2-L2
|
Antibody Info | ||||
| Antigen Name |
Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Therapeutic Target |
Stimulator of interferon genes protein (STING1)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||